SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMUNE NETWORK RESEARCH (VSE:IMM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: burner who wrote (10)2/12/1997 7:44:00 AM
From: pete meyer   of 134
 
Any thoughts on this ..if he could not swing the cat left to right
will it work to swing right to left ???

Immune Entered Into Agreement With Bio Fluorescent Technologies

IMMUNE NETWORK RESEARCH LTD. ("IMM-V;IMNWF-L")

BIO-FLUORESCENT TECHNOLOGIES, INC. ("BFTK-L")

- Immune Entered Into Agreement With Bio-Fluorescent Technologies

Richard L. Richards, Director of Immune Network Research Ltd. (the "Company") is pleased to
announce that the Company has entered into an agreement in principle with Bio-Fluorescent
Technologies, Inc. pursuant to which Bio-Fluorescent will acquire the assets of the Company for
approximately 9,000,000 shares of Bio-Fluorescent Technologies, Inc.. Bio-Fluorescent
currently has 5,937,387 shares outstanding as well as options to purchase an additional 866,667
shares. The transaction is subject to several conditions including shareholder approval, regulatory
approval, satisfactory results from due diligence searches and finalization of the precise structure
of the transaction. The costs of the transaction will be paid by Bio-Fluorescent Technologies, Inc.

Bio-Fluorescent Technologies, Inc. is a public Nevada corporation whose common shares trade
on the over-the-counter market in the United States. The closing price of the Bio-Fluorescent
Technologies, Inc. shares on February 10, 1997 was US $0.34 per share.

The primary reason for forming a relationship with Bio-Fluorescent Technologies, Inc. is to
enable the Company's technology to take advantage of the large capital markets for
biotechnology companies in the U.S. Shareholders of the Company will benefit by being able to
participate in the development of the Company's assets through Bio-Fluorescent Technologies,
Inc.

The transaction is expected to close on approximately May 15, 1997.

TEL: (604) 689-3923 Richard L. Richards, FAX: (604) 684-5854 Director TEL: E-Mail:
www.stockgroup.com/imm.html

________

(c) Corporate Dissemination Services Inc. All rights reserved.

Tel:(604) 689-1101 Fax:(604) 689-1106

RapidFAX (tm) - To get the NEWS as it happens, call (604) 689-3041.

This release processed by Canstock at 6:44:17 Pacific Time
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext